EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ganglioside GD2 Contributes to a Stem‐Like Phenotype in Intrahepatic Cholangiocarcinoma

Antonella Mannini, Mirella Pastore, Alessia Giachi, Margherita Correnti, Elena Spínola Lasso, Tiziano Lottini, Benedetta Piombanti, Ignazia Tusa, Elisabetta Rovida, Cédric Coulouarn, Jesper B Andersen iD, Monika Lewinska und 17 weitere

Liver International · 2025-01 · 45 (1)

DOI: 10.1111/liv.16208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 26.12.2024. Verfasst von Antonella Mannini und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Gangliosides, Bile Duct Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione. AIRC per la ricerca sul cancro ETS, Cassa di Risparmio di Pistoia e Pescia, COST Action EURO-CHOLANGIO-NET.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims GD2, a member of the ganglioside (GS) family (sialic acid‐containing glycosphingolipids), is a potential biomarker of cancer stem cells (CSC) in several tumours. However, the possible role of GD2 and its biosynthetic enzyme, GD3 synthase (GD3S), in intrahepatic cholangiocarcinoma (iCCA) has not been explored.

Methods

The stem‐like subset of two iCCA cell lines was enriched by sphere culture (SPH) and compared to monolayer parental cells (MON). GS profiles were evaluated by chromatography, after feeding with radioactive sphingosine. Membrane GD2 expression was evaluated by FACS, and the expression of enzymes of GS biosynthesis was analysed by RT‐qPCR. The modulation of stem features by GS was investigated in vitro and in vivo using GD3S‐overexpressing cells and corroborated by global transcriptomic analysis.

Results

GS composition was markedly different comparing SPH and MON. Among complex GS, iCCA‐SPH showed increased GD2 levels, in agreement with the high expression levels of GD3 and GM2/GD2 synthases. iCCA cells overexpressing GD3S had higher sphere‐forming ability, invasive properties and drug resistance than parental cells. NOD/SCID mice implanted with CCLP1 cells overexpressing GD3S developed larger tumours than control cells. By global transcriptomic analysis, ontology investigation identified 74 processes shared by the iCCA‐SPH and GD3S‐transfected cells, with enrichment for development and morphogenesis processes, MAPK signalling and locomotion. In a cohort of patients with iCCA, GD3S expression was correlated with lymph node invasion, indicating a possible relevance of GD3S in the clinical setting.

Conclusions

The profile of GS derivatives regulates the stem‐like properties of iCCA cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaGangliosidesBile Duct NeoplasmsNeoplastic Stem CellsSialyltransferasesHumansCell Line, TumorAnimalsPhenotypeMiceMice, SCID

Stichwörter der Autor:innen

GD2 gangliosideGD3 synthase (o ST8SIA1)cancer stem cellscancer stemness biomarkerintrahepatic cholangiocarcinoma

Substanzen

GangliosidesSialyltransferasesganglioside, GD2alpha-N-acetylneuraminate alpha-2,8-sialyltransferase

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
  • Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
  • Univ Rennes, Inserm, Inra, Institut NUMECAN (Nutrition Metabolisms and Cancer)-UMR_S 1241, UMR_A 1341, Rennes, France.
  • Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
  • Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Jesper B Andersen, Fabio Marra, Chiara Raggi

Förderung

  • Fondazione. AIRC per la ricerca sul cancro ETS
  • Cassa di Risparmio di Pistoia e Pescia
  • COST Action EURO-CHOLANGIO-NET
  • EURO-CHOLANGIO-NET and Precision-BTC-Network granted by COST ACTION

Zitieren

APA

Mannini, A., Pastore, M., Giachi, A., Correnti, M., Spínola Lasso, E., Lottini, T., Piombanti, B., Tusa, I., Rovida, E., Coulouarn, C., Andersen, J. B., Lewinska, M., Campani, C., Battula, V. L., Yuan, B., Aureli, M., Carsana, E. V., Peraldo Neia, C., Ostano, P., …, & Raggi, C. (2025). Ganglioside GD2 Contributes to a Stem‐Like Phenotype in Intrahepatic Cholangiocarcinoma. Liver International, 45(1). https://doi.org/10.1111/liv.16208

Vancouver

Mannini A, Pastore M, Giachi A, Correnti M, Spínola Lasso E, Lottini T, et al. Ganglioside GD2 Contributes to a Stem‐Like Phenotype in Intrahepatic Cholangiocarcinoma. Liver International. 2025;45(1). doi:10.1111/liv.16208

BibTeX
@article{Mannini2025,
  author = {Mannini, Antonella and Pastore, Mirella and Giachi, Alessia and Correnti, Margherita and Spínola Lasso, Elena and Lottini, Tiziano and Piombanti, Benedetta and Tusa, Ignazia and Rovida, Elisabetta and Coulouarn, Cédric and Andersen, Jesper B and Lewinska, Monika and Campani, Claudia and Battula, V Lokesh and Yuan, Bin and Aureli, Massimo and Carsana, Emma V and Peraldo Neia, Caterina and Ostano, Paola and Tani, Alessia and Nosi, Daniele and Vanni, Anna and Maggi, Laura and Di Tommaso, Luca and Comito, Giuseppina and Madiai, Stefania and Arcangeli, Annarosa and Marra, Fabio and Raggi, Chiara},
  title = {Ganglioside GD2 Contributes to a Stem‐Like Phenotype in Intrahepatic Cholangiocarcinoma},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {1},
  doi = {10.1111/liv.16208}
}
Kostenlos starten →